1
|
Castleman B, Iverson L and Menendez VP:
Localized mediastinal lymph node hyperplasia resembling thymoma.
Cancer. 9:822–830. 1956.PubMed/NCBI View Article : Google Scholar
|
2
|
Bonekamp D, Horton KM, Hruban RH and
Fishman EK: Castleman disease: The great mimic. Radiographics.
31:1793–1807. 2011.PubMed/NCBI View Article : Google Scholar
|
3
|
Aygun C, Tekin MI, Demirhan B,
Peskircioglu CL, Agildere M and Ozkardes H: A case of incidentally
detected Castleman's disease with retroperitoneal paravertebral
localization. Int J Urol. 7:22–25. 2000.PubMed/NCBI View Article : Google Scholar
|
4
|
Latters R and Pachter MR: Benign lymphoid
masses of probable hamartomatous nature. Analysis of 12 cases.
Cancer. 15:197–214. 1962.PubMed/NCBI View Article : Google Scholar
|
5
|
Giaretta MI, Hyun J and Gibbons JM Jr:
Angiomatous lymphoid hamartoma as a pelvic mass. A case report.
Obstet Gynecol. 38:391–394. 1971.PubMed/NCBI
|
6
|
Emson HE: Extrathoracic angiofollicular
lymphoid hyperplasia with coincidental myasthenia gravis. Cancer.
31:241–245. 1973.PubMed/NCBI View Article : Google Scholar
|
7
|
Bainbridge ET: Angiomatous lymphoid
hamartoma of the pelvis. Br J Obstet Gynaecol. 83:823–826.
1976.PubMed/NCBI View Article : Google Scholar
|
8
|
Tanaka T, Kobayashi K, Sho T and Hamazaki
M: Castleman's lymphoma among Japanese population. Acta Pathol Jpn.
26:547–559. 1976.PubMed/NCBI View Article : Google Scholar
|
9
|
Kumar D and Shah S: Angiomatous lymphoid
hamartoma or pseudolymphoma of pelvic retroperitoneum: Clinical
significance and evaluation of pelvic ureter. Urology. 13:677–681.
1979.PubMed/NCBI View Article : Google Scholar
|
10
|
Goodman K, Baim RS, Clair MR and Perkes
EA: Angiomatous lymphoid hamartoma of the pelvis. Characteristic
calcification and computed tomographic appearance. Radiology.
146(728)1983.PubMed/NCBI View Article : Google Scholar
|
11
|
Ylinen K, Sarlomo-Rikala M and Laatikainen
T: Pelvic Castleman disease mimicking an adnexal tumor. Obstet
Gynecol. 85:894–897. 1995.PubMed/NCBI View Article : Google Scholar
|
12
|
MacDonald SR, Lurain JR, Hoff F,
Variakojis D and Fishman DA: Castleman disease presenting as a
pelvic mass. Obstet Gynecol. 87:875–877. 1996.
|
13
|
Gaunt GA, Gostout BS, Remstein E and Cliby
WA: Pelvic Castleman disease presenting as vaginal occlusion.
Obstet Gynecol. 100:1082–1085. 2002.
|
14
|
Nakamura Y, Tokuyama O, Muso A, Kawamura
N, Yasui T and Ishiko O: Asymptomatic pelvic Castleman disease in
an infertile woman: Case report. Arch Gynecol Obstet. 269:156–158.
2004.PubMed/NCBI View Article : Google Scholar
|
15
|
Sato A: Castleman's disease in the pelvic
retroperitoneum: A case report and review of the Japanese
literature. Int J Surg Case Rep. 4:19–22. 2013.PubMed/NCBI View Article : Google Scholar
|
16
|
Lee J, Paek J, Lee YH, Kong TW, Chang SJ
and Ryu HS: Pelvic Castleman's disease presenting as an adnexal
tumor in a young woman. Obstet Gynecol Sci. 58:323–326.
2015.PubMed/NCBI View Article : Google Scholar
|
17
|
Schelble AP and Merritt DF: Pelvic
Castleman's disease presenting as an adnexal mass in an adolescent.
J Pediatr Adolesc Gynecol. 32:86–89. 2019.PubMed/NCBI View Article : Google Scholar
|
18
|
Castleman B and Towne VW: Case records of
the Massachusetts General Hospital: Case No. 40231. N Engl J Med.
250:1001–1005. 1954.PubMed/NCBI View Article : Google Scholar
|
19
|
Talat N, Belgaumkar AP and Schulte KM:
Surgery in Castleman's disease: A systematic review of 404
published cases. Ann Surg. 255:677–684. 2012.PubMed/NCBI View Article : Google Scholar
|
20
|
Roca B: Castleman's disease. A review.
AIDS Rev. 11:3–7. 2009.PubMed/NCBI
|
21
|
Shah D, Darji P, Lodha S and Bolla S:
Unicentric Castleman's disease of abdomen. J Radiol Case Rep.
7:26–33. 2013.PubMed/NCBI View Article : Google Scholar
|
22
|
Keller AR, Hochholzer L and Castleman B:
Hyaline-vascular and plasma-cell types of giant lymph node
hyperplasia of the mediastinum and other locations. Cancer.
29:670–683. 1972.PubMed/NCBI View Article : Google Scholar
|
23
|
Seco JL, Velasco F, Manuel JS, Serrano SR,
Tomas L and Velasco A: Retroperitoneal Castleman's disease.
Surgery. 112:850–855. 1992.PubMed/NCBI
|
24
|
Takihara H, Yamakawa G, Baba Y, Takahashi
M and Ishihara T: Castleman disease. Unusual retroperitoneal
location indistinguishable from malignant tumor in preoperative
angiographic appearance. Urology. 41:162–164. 1993.PubMed/NCBI View Article : Google Scholar
|
25
|
Chung EM, Biko DM, Arzamendi AM, Meldrum
JT and Stocker JT: Solid tumors of the peritoneum, omentum, and
mesentery in children: radiologic-pathologic correlation: From the
radiologic pathology archives. Radiographics. 35:521–546.
2015.PubMed/NCBI View Article : Google Scholar
|
26
|
Ko SF, Hsieh MJ, Ng SH, Lin JW, Wan YL,
Lee TY, Chen WJ and Chen MC: Imaging spectrum of Castleman's
disease. AJR Am J Roentgenol. 182:769–775. 2004. View Article : Google Scholar
|
27
|
Hill AJ, Tirumani SH, Rosenthal MH,
Shinagare AB, Carrasco RD, Munshi NC, Ramaiya NH and Howard SA:
Multimodality imaging and clinical features in Castleman disease:
Single institute experience in 30 patients. Br J Radiol.
88(20140670)2015.PubMed/NCBI View Article : Google Scholar
|
28
|
Lee ES, Paeng JC, Park CM, Chang W, Lee
WW, Kang KW, Chung JK and Lee DS: Metabolic characteristics of
Castleman disease on 18F-FDG PET in relation to clinical
implication. Clin Nucl Med. 38:339–342. 2013.PubMed/NCBI View Article : Google Scholar
|
29
|
Oida Y, Shimizu K, Mukai M, Imaizumi T,
Nakamura M and Makuuchi H: FDG-PET and diffusion-weighted MR
imaging appearance in retroperitoneal Castleman's disease: A case
report. Clin Imaging. 32:144–146. 2008.PubMed/NCBI View Article : Google Scholar
|
30
|
Murphy SP, Nathan MA and Karwal MW:
FDG-PET appearance of pelvic Castleman's disease. J Nucl Med.
38:1211–1212. 1997.PubMed/NCBI
|
31
|
Nakayama T, Yoshimitsu K, Irie H, Aibe H,
Tajima T, Shinozaki K, Nishie A, Asayama Y, Kakihara D, Matsuura S
and Honda H: Usefulness of the calculated apparent diffusion
coefficient value in the differential diagnosis of retroperitoneal
masses. J Magn Reson Imaging. 20:735–742. 2004.PubMed/NCBI View Article : Google Scholar
|
32
|
Platzek I, Beuthien-Baumann B, Schramm G,
Maus J, Laniado M, Kotzerke J, van den Hoff J and Schuler M: FDG
PET/MR in initial staging of sarcoma: Initial experience and
comparison with conventional imaging. Clin Imaging. 42:126–132.
2017.PubMed/NCBI View Article : Google Scholar
|
33
|
Summerfield GP, Taylor W, Bellingham AJ
and Goldsmith HJ: Hyaline-vascular variant of angiofollicular lymph
node hyperplasia with systemic manifestations and response to
corticosteroids. J Clin Pathol. 36:1005–1011. 1983.PubMed/NCBI View Article : Google Scholar
|
34
|
Bowne WB, Lewis JJ, Filippa DA, Niesvizky
R, Brooks AD, Burt ME and Brennan MF: The management of unicentric
and multicentric Castleman's disease: A report of 16 cases and a
review of the literature. Cancer. 85:706–717. 1999.PubMed/NCBI View Article : Google Scholar
|
35
|
Kiguchi H, Ishii T, Ishikawa Y, Masuda S,
Asuwa N, Yamafuji K and Takahashi T: Castleman's disease of the
abdomen and pelvis: Report of three cases and a review of the
literature. J Gastroenterol. 30:661–666. 1995.PubMed/NCBI View Article : Google Scholar
|
36
|
Corcione F, Caiazzo P, Cuccurullo D,
Settembre A, Miranda L, Pirozzi F and Caracino V: Laparoscopic
treatment of unicentric Castleman's disease with abdominal
localization. J Laparoendosc Adv Surg Tech A. 15:400–404.
2005.PubMed/NCBI View Article : Google Scholar
|
37
|
Brusciano L, Rossetti G, Maffettone V,
Napolitano V, Izzo D, Pizza F, Russo G, Russo F, del Genio G and
del Genio A: Laparoscopic treatment of an uncommon abdominal
localization of Castleman disease. Surg Laparosc Endosc Percutan
Tech. 15:241–243. 2005.PubMed/NCBI View Article : Google Scholar
|